The search for pharmaceutical treatments for Alzheimer’s and dementia has so far been unsuccessful, but a new drug discovery center aims to change that.
The National Institutes of Health is gifting $36 million to fund the new center, one of two to be established nationwide. The Indiana University School of Medicine will partner with Purdue University to develop research tools and technologies to identify new treatment options.
Alan Palkowitz will lead the center. He was previously the vice president of discovery chemistry research at Eli Lilly.